|
Model Number 8780 |
Device Problem
Volume Accuracy Problem (1675)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id 8637-20, serial# (b)(4), implanted: (b)(6) 2013, explanted: (b)(6) 2015, product type: pump.(b)(4).
|
|
Event Description
|
Information received from a healthcare provider (hcp) via manufacturer representative regarding a patient receiving dilaudid (unknown dose/concentration).Indication for use was noted as spinal pain.It was reported that there was a catheter event.A dye study was performed because the patient was having volume discrepancies at refills.The dye study prompted a catheter revision that led to a replaced of the catheter on (b)(6) 2015.The exact volumes were unknown but they were getting back more than expected.The manufacturer representative believed the volume discrepancies went back to october of 2015.While in the case the physician decided to replace the pump as well.The patient was doing well per the manufacturer representative.No symptoms were reported.
|
|
Manufacturer Narrative
|
Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.(b)(4).
|
|
Event Description
|
Additional information was received from a healthcare provider (hcp) via a device manufacturer representative (rep).While it was reported that during refill there was more drug taken out than on the 8840 (physician programmer) printout, the specific volumes were still not specified.It was reported there was no patient injury, and that the patient recovered without sequela following the replacement.No further information was provided.
|
|
Manufacturer Narrative
|
Concomitant product(s): product id: 8637-20, serial# ngp377003h, implanted: (b)(6) 2013, explanted: (b)(6) 2015, product type: pump.The previously reported indication for use, spinal pain, is being corrected to non-malignant pain.Analysis of the returned catheter segment found a non-significant anomaly, specifically a tear in the seal of the sc (sutureless) connector near the guide ring.Upon return, the device was interrogated and was found to have been programmed with dilaudid 15.0mg/ml at a dose of 5.498 mg per day, bupivacaine 15.0mg/ml at a dose of 5.498 mg per day and clonidine 750 mcg/ml at a dose of 274.91 mcg per day.The previously reported conclusion code is being updated.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|